Covered recipient · General Payments record
ANINDYA K SEN
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2025
$7,323.89
- Reported across 507 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $270.48 | 18 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $171.43 | 13 |
| Novo Nordisk AS | $42.84 | 2 |
| PFIZER INC. | $22.95 | 1 |
| Merck Sharp & Dohme Corporation | $18.00 | 1 |
| GlaxoSmithKline, LLC. | $15.26 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $12.52 | 03/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204165603 | CMS |
| ABBVIE INC. | $10.77 | 04/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204165609 | CMS |
| ABBVIE INC. | $14.42 | 04/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204165615 | CMS |
| ABBVIE INC. | $9.37 | 04/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204165621 | CMS |
| ABBVIE INC. | $17.11 | 05/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204165627 | CMS |
| ABBVIE INC. | $13.12 | 05/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204165632 | CMS |
| ABBVIE INC. | $15.54 | 05/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204165636 | CMS |
| ABBVIE INC. | $9.98 | 07/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204165643 | CMS |
| ABBVIE INC. | $22.26 | 08/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204165649 | CMS |
| ABBVIE INC. | $11.66 | 09/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204165656 | CMS |
| ABBVIE INC. | $11.64 | 11/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204165660 | CMS |
| ABBVIE INC. | $8.36 | 11/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204165667 | CMS |
| ABBVIE INC. | $14.68 | 12/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204165673 | CMS |
| GlaxoSmithKline, LLC. | $15.26 | 04/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190337341 | CMS |
| Merck Sharp & Dohme LLC | $18.00 | 02/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238369451 | CMS |
| Novo Nordisk Inc | $28.39 | 03/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188679735 | CMS |
| Novo Nordisk Inc | $14.45 | 06/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188600040 | CMS |
| PFIZER INC. | $22.95 | 04/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229201455 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.